TP53 and hepatocellular carcinoma: Indeed, inactivation of the TP53-RB pathway observed in approximately 30% of HBV-related HCC is a common event due to frequent mutations in TP53 gene as well as in ATM and RPS6KA3, encoding p53-activating kinases [17,18,19].